GKB OphthalmicsBOM:533212 -1.61%68 Gross Margin % is 34.21% as of Mar. 2026, which is 15% above its 10-year median of 29.81. GuruFocus rates BOM:533212 with a GF Score™ of 68/100 and a GF Value™ of ₹161.63 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 807 Medical Devices & Instruments companies, GKB Ophthalmics ranks worse than 82.16% on this metric.
The historical rank and industry rank for GKB Ophthalmics's Gross Margin % or its related term are showing as below:
BOM:533212'
s Gross Margin % Range Over the Past 10 Years
Min: 21.58 Med: 29.81 Max: 32.61
Current: 29.29
During the past 13 years, the highestGross Margin % of GKB Ophthalmics was 32.61%. The lowest was 21.58%. And the median was 29.81%.
BOM:533212's Gross Margin % is ranked worse than 82.16% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs BOM:533212: 29.29
GKB Ophthalmics had a gross margin of 34.21% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for GKB Ophthalmics was 0.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
GKB Ophthalmics had a gross margin of 34.21% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
GKB Ophthalmics Gross Margin % Related Terms
GKB Ophthalmics Gross Margin % Historical Data
* Premium members only.
The historical data trend for GKB Ophthalmics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
GKB Ophthalmics (BOM:533212) has a Gross Margin % of 34.21% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on GKB Ophthalmics and its competitors. This is 15% above median its historical median of 29.81. Over the past decade, GKB Ophthalmics' Gross Margin % has ranged from 21.58 to 32.61. According to the industry distribution chart, GKB Ophthalmics ranks #663 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 82.2%.
Is GKB Ophthalmics' Gross Margin % too high?
GKB Ophthalmics' current Gross Margin % of 34.21% is 15% above median its 10-year median of 29.81. Over the past 10 years, this metric has ranged from a low of 21.58 to a high of 32.61. The Medical Devices & Instruments industry median Gross Margin % is 52.03. GKB Ophthalmics' value of 34.21% is 34.2% below this industry median. Based on the distribution chart, GKB Ophthalmics ranks #663 out of 807 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GKB Ophthalmics has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #663 out of 807 companies for Gross Margin %. This places GKB Ophthalmics in the lower half of its industry. The industry median Gross Margin % is 52.03. GKB Ophthalmics' value of 34.21% is 34.2% below this benchmark. Historically, GKB Ophthalmics' own Gross Margin % has ranged from 21.58 to 32.61 over the past decade. While the company's 10-year median is 29.81 vs. the industry median of 52.03, GKB Ophthalmics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GKB Ophthalmics's current Gross Margin % of 34.21% is 34.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on GKB Ophthalmics and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GKB Ophthalmics's current Gross Margin % is 34.21%, which is 15% above median its own 10-year median of 29.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Possible Value Trap. The stock's GF Value™ is ₹161.63, compared to a current price of ₹60.00 — trading 62.9% below its estimated fair value. The current Gross Margin % is 34.21%, which is 15% above median its 10-year median of 29.81 and 34.2% below the Medical Devices & Instruments industry median of 52.03. GKB Ophthalmics' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Gross Margin % is 34.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹60.00 is trading 62.9% below its estimated GF Value™ of ₹161.63.
GuruFocus considers GKB Ophthalmics to be Possible Value Trap.
Key valuation signals for BOM:533212:
Gross Margin %: 34.21% (15% above median its 10-year median of 29.81)
GF Value™: ₹161.63 vs. price of ₹60.00 (62.9% below fair value)
Industry Position: 34.2% below the Medical Devices & Instruments median (#663 of 807)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
68GF Score
Get the complete analysis for BOM:533212
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
